Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
  Breaking News: FDA Approves Triumeq, New Once-Daily Combination Pill
   
Ask the Experts About

Choosing Your MedsChoosing Your Meds
           
Rollover images to visit our other forums!
Recent AnswersAsk a Question
  
  • Email Email
  • Glossary Glossary


kidney problems with viread?
Nov 23, 2003

Dr. Gerald,

How common are renal problems associated to arvs like Viread?

Hoffman

Response from Dr. Pierone

Kidney problems with Viread are uncommon. In the pivotal studies that compared Viread to Zerit in treatment-nave patients there were no differences between the groups and kidney problems were rare. In more advanced patients in a salvage setting there have been more reports of kidney problems related to Viread compared to patients that received Ziagen (expanded access in Canada). Overall, Viread is one of the best tolerated HIV medications and does not appear to be associated with kidney problems although longer follow up studies are underway to monitor this issue.



Previous
closer examination of this target needed with improvement treatment options!
Next
Can I start treatment

  
  • Email Email
  • Glossary Glossary

 Get Email Notifications When This Forum Updates or Subscribe With RSS


 
Advertisement



Q&A TERMS OF USE

This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint

Advertisement